IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Chandan Healthcare IPO is a book build IPO listing on NSE EMERGE exchange. The company is based in Lucknow and caters to Healthcare - Hospitals And Clinic sector. Unistone Capital Private is the merchant banker of Chandan Healthcare IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 28th September 2024.
Chandan Healthcare IPO posted revenues of Rs 223.99 crores and PAT of Rs 23.23 crores in FY25 on annualised basis.Financial results of Chandan Healthcare IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
Chandan Healthcare IPO PAT Margin is 9.63%, ROCE (Return on Capital Employed) is 271.70% as per latest financial. The below table shows Chandan Healthcare IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
The market Capitalisation of Chandan Healthcare IPO is Rs 388.79 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Chandan Healthcare IPO prospectus highlights an Return on Equity (ROE) of 15%, Return on Assets (ROA) of 12%, and an EBITDA Margin of 18%, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Chandan Healthcare IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Chandan Healthcare IPO is ₹388.79 Cr, based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Chandan Healthcare IPO has a Price-to-Earnings (PE) ratio of 16.74 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Chandan Healthcare IPO reported revenue of ₹223.99 Cr in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Chandan Healthcare IPO provide insights into sales growth, market demand, and business scalability.
Chandan Healthcare recorded an EBITDA of ₹ 40.12 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Chandan Healthcare Profit After Tax (PAT) is ₹21.53 Cr, reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 223.65 Cr.
EBITDA Margin:
17.94
%
Net Worth: [●]
Market Capitalisation:
₹ 388.79 Cr.
P/E:
16.74 times
P/BV: 3.62 times
EV/EBITDA: 10.88 times
Chandan Healthcare operates in Healthcare - Hospitals And Clinic and Diagnostic Service Provider In The Northern Region. It Covers Pathological And Radio-logical Testing Services. The Issue is listed on NSE EMERGE in Feb, 2025. Chandan Healthcare IPO size was 107.36 with Issue price of 159.00 .
Merchant Banker(s) of Chandan Healthcare IPO: Unistone Capital Private Limited
Chandan Healthcare IPO subscription was 7.04 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Chandan Healthcare IPO listed at a listing price of 165.10 against the offer price of 159.00.
The current market price of Chandan Healthcare is 202.00.
Why Us?
